HNRNPDL-related muscular dystrophy: expanding the clinical, morphological and MRI phenotypes
Andrés Berardo, Ana Lía Taratuto(Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia), Claudia Cejas(Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia), M. Saccoliti(Instituto de Neurología de Buenos Aires), Fábio Barroso(Université Paris-Sud), Xavière Lornage(Centre National de la Recherche Scientifique), Mridul Johari(University of Helsinki), Guy Brochier(Inserm), Johann Böhm(Centre National de la Recherche Scientifique), Bjarne Udd(Folkhälsans Forskningscentrum), Jocelyn Laporte(Centre National de la Recherche Scientifique), Norma B. Romero(Centre National de la Recherche Scientifique), Alberto Dubrovsky, Mai Thao Bui(Institut de Myologie), Teresinha Evangelista(Newcastle University)
Cited by 55
Related Papers
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484
Mutations in dynamin 2 cause dominant centronuclear myopathy
|Nature Genetics|2005|462